Rheumatology International

, Volume 26, Issue 9, pp 810–817

All-trans-retinoic acid suppresses interferon-γ and tumor necrosis factor-α; a possible therapeutic agent for rheumatoid arthritis

  • Yuji Nozaki
  • Chise Tamaki
  • Toshiaki Yamagata
  • Masafumi Sugiyama
  • Shinya Ikoma
  • Koji Kinoshita
  • Masanori Funauchi
Original Article

Abstract

Objectives: To study the effects of all-trans-retinoic acid (ATRA), we determined the proliferation and cytokine production by peripheral blood mononuclear cells (PBMCs) and CD4+ T cells in healthy volunteers and patients with rheumatoid arthritis (RA), and explored the possibility of using ATRA as a therapeutic agent for autoimmune diseases. Methods: Proliferation of these cells was determined by modified MTT assay, and expression of CC chemokine receptors 4 (CCR4) and CCR5 was determined by flow cytometry. Production and expression of interferon (IFN)-γ, interleukin (IL)-2, IL-4, and tumor necrosis factor (TNF)-α was determined by Enzyme-Linked Immunosorbent Assay (ELISA) and reverse transcription-polymerase chain reaction (RT-PCR). The presence of STAT6 protein was determined by Western blot analysis. Results: ATRA did not affect the proliferation or production of IL-2 and IL-4. We did not detect STAT6 protein, and saw no evidence of the differentiation of PBMCs to Th1 or Th2 cells. In contrast, ATRA suppressed the production of IFN-γ and TNF-α significantly. There were no significant differences between the healthy volunteers and RA patients. Conclusions: ATRA was demonstrated to affect the cytokine production of IFN-γ and TNF-α. ATRA might be useful in the treatment of autoimmune diseases such as RA.

Keywords

Th1/Th2 cells Cytokine All-trans-retinoic acid Autoimmune disease 

References

  1. 1.
    Romagnani S (1995) Biology of human TH1 and TH2 cells. J Clin Immunol 15:121–129CrossRefPubMedGoogle Scholar
  2. 2.
    Hayashi M, Martinez OM, Garcia-Kennedy (1995) Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation 60:1538–1553CrossRefGoogle Scholar
  3. 3.
    Lafaille JJ (1998) The role of helper T cell subset in autoimmune disease. Cytokine Growth Factor Rev 9:139–151CrossRefPubMedGoogle Scholar
  4. 4.
    Barton MT, Vitetta ES (1990) Interleukin-4 induces changes in the chromatin structure of the Ig switch region in resting B cells before switch recombination. J Exp Med 172:375–378CrossRefPubMedGoogle Scholar
  5. 5.
    Ichiki T, Takahashi W, Watanabe T (1993) Regulation of the expression of human C germline transcript. J Immunol 150:5408–5417PubMedGoogle Scholar
  6. 6.
    Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397–440CrossRefPubMedGoogle Scholar
  7. 7.
    Feldmann M, Brennan FM, Maini RN (1996) Rheumatoid arthritis. Cell 85:307–310CrossRefPubMedGoogle Scholar
  8. 8.
    Mathew JS, Sharma RP (2000) Effect of all-trans-retinoic acid on cytokine production in a murine macrophage cell line. Int J Immunopharmacol 22:693–706CrossRefPubMedGoogle Scholar
  9. 9.
    Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G (1991) Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO J 10:4025–4031PubMedGoogle Scholar
  10. 10.
    Ishiyawa M, Hideyuki T, Shiga M (1996) A combined assay of cell viability and in vitro cytotoxity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 19:1518–1520PubMedGoogle Scholar
  11. 11.
    Diefenbach A, Schindler H, Rollinghoff M, Yokoyama WM, Bogdan C (1999) Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science 284:951–955CrossRefPubMedGoogle Scholar
  12. 12.
    Jiang XL, Dillehay DL, Everson MP, Tilden AB, Lamon EW (1992) Potentiation of IL-2-induced T-cell proliferation by retinoids. Int J Immunopharmacol 14:195–204CrossRefPubMedGoogle Scholar
  13. 13.
    Sidell N, Ramsdell F (1988) Retinoic acid upregulates interleukin-2 receptors on activated human thymocytes. Cell Immunol 115:299–309CrossRefPubMedGoogle Scholar
  14. 14.
    Felli MP, Vacca A, Meco D, Screpanti I, Farina AR, Maroder M, Martinotti S, Petrangeli E, Frati L, Gulino A (1991) Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. Mol Cell Biol 11:4771–4778PubMedGoogle Scholar
  15. 15.
    Kinoshita K, Yoo BS, Nozaki Y, Sugiyama M, Ikoma S, Ohno M, Funauchi M, Kanamaru A (2003) Retinoic acid reduces autoimmune renal injury and increases survival in NZB/WF1 mice. J Immunol 170:5793–5798PubMedGoogle Scholar
  16. 16.
    Racke MK, Burnett D, Pak SH, Albert PS, Cannella B, Raine CS, McFarlin DE, Scott DE (1995) Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 154:450–458PubMedGoogle Scholar
  17. 17.
    Kaplan MH, Schindler U, Smiley ST, Grusby MJ (1996) Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313–319CrossRefPubMedGoogle Scholar
  18. 18.
    Konta T, Xu Q, Furusu A, Nakayama K, Kitamura M (2001) Selective roles of retinoic acid receptor and retinoid X receptor in the suppression of apoptosis by all-trans-retinoic acid. J Biol Chem 16:12697–12701CrossRefGoogle Scholar
  19. 19.
    Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10:405–455CrossRefPubMedGoogle Scholar
  20. 20.
    Gerli R, Bistoni O, Russano A, Fiorucci S, Borgato L, Cesarotti ME, Lunardi C (2002) In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease. Clin Exp Immunol 129:549–555Google Scholar
  21. 21.
    Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A, Gal A, Kunaver M, Zenz P, Smolen JS (1999) Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology 38:202–213CrossRefPubMedGoogle Scholar
  22. 22.
    Canete JD, Martinez SE, Farres J, Sanmarti R, Blay M, Gomez A, Salvador G, Munoz-Gomez J (2000) Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis 59:263–268CrossRefPubMedGoogle Scholar
  23. 23.
    Dayer JM (2002) Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis? J Rheumatol 65:10–15Google Scholar
  24. 24.
    Bathon JM, Martin RW, Fleischmann RM et al (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1586–1593CrossRefPubMedGoogle Scholar
  25. 25.
    Hallegua DS, Weisman MH (2002) Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases. Ann Rheum Dis 61:960–967CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Yuji Nozaki
    • 1
  • Chise Tamaki
    • 1
  • Toshiaki Yamagata
    • 1
  • Masafumi Sugiyama
    • 1
  • Shinya Ikoma
    • 1
  • Koji Kinoshita
    • 1
  • Masanori Funauchi
    • 1
  1. 1.Department of Nephrology and RheumatologyKinki University School of MedicineOsakaJapan

Personalised recommendations